LamivudineReverse Transcriptase InhibitorsHepatitis B, ChronicOrganophosphonatesHepatitis B virusAntiviral AgentsHepatitis B e AntigensAdenineDrug TherapyAnti-HIV AgentsDrug Resistance, ViralDrug Therapy, CombinationZidovudineStavudineHepatitis BDideoxynucleosidesHIV InfectionsDNA, ViralNevirapineAlanine TransaminaseBenzoxazinesViral LoadTreatment OutcomeHepatitis B Surface AntigensHIV-1IndinavirDidanosinePyrimidinonesNucleosidesAntiretroviral Therapy, Highly ActiveOxazinesTreatment FailureDrug Resistance, Multiple, ViralHepatitis B AntibodiesRecurrenceGene Products, polMutationNelfinavirHIV Reverse TranscriptaseZalcitabineCD4 Lymphocyte CountLiver TransplantationGuanineLopinavirRitonavirHIV Protease InhibitorsInterferon-alphaDideoxynucleotidesDrug Administration ScheduleAnti-Arrhythmia AgentsRetrospective StudiesHepatitis B Core AntigensLiver CirrhosisRNA, ViralVirus ActivationCytidine TriphosphateArabinofuranosyluracilDouble-Blind MethodImmunoglobulinsInfectious Disease Transmission, VerticalTime FactorsFollow-Up Studies2-AminopurineDrugs, GenericDrug CombinationsAntihypertensive AgentsGenotypeTherapeutic EquivalencyProspective StudiesDrug Resistance, MicrobialDrug CostsVirus ReplicationPharmacogeneticsAnti-Retroviral AgentsPolyethylene GlycolsDrug MonitoringCost-Benefit AnalysisPatient Compliance